CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
CHA Comments on CMS State Directed Payment Proposed Rule on Children’s Health
Limits on SDPs will impact children’s access to care
May 21, 2026
Statement for the Record: House Ways and Means Committee Hearing with Health System CEOs
Children's Hospital Association is asking lawmakers to consider the significant financial and regulatory pressures facing children’s hospitals.
May 06, 2026
CHA Submits LHHS Appropriations Testimony
CHA submitted witness testimony to the LHHS Appropriations Subcommittees detailing FY27 requests on workforce, mental health, preparedness, research, and safety.
April 29, 2026
